Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...

Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...

New York drugmaker Pfizer and Mainz, Germany, immunotherapy company BioNTech said the European Commission, which generally follows CHMP's advice, will now review the recommendation, with a final ...

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants1 – compared to ...

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants1 – compared to 202 ...

Today, anthrax remains one of the deadliest and easiest biological weapons to produce. Yet 80 percent of the U.S. supply of ...

Researchers looked at how the vaccine affected patients' corneas - the clear front part of the eye that allows light to come ...

TAMPA — Florida’s top health official blasted the manufacturer’s of mRNA COVID-19 vaccines and wants the federal government to do more to help those he described as the “vaccine injured.” Florida ...

U.N. health officials have estimated that more than 14 million children did not receive a single vaccine last year.

In light of recent revelations surrounding a new intranasal COVID-19 vaccine candidate, there is growing concern that the American public is once again being led into potentially dangerous territory ...

Amid growing concerns over the safety of COVID-19 vaccines, a significant lawsuit against prominent figures in the pharmaceutical industry and public health has taken a dramatic turn. Three new ...